A government crackdown on cheaper copies of Ozempic and similar diabetes and weight-loss drugs was intended to shut the door on that booming market. It hasn’t exactly worked out that way ...

Ozempic Knockoffs Survive Crackdown Thanks to Loophole. Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations. By .